Andreas LOEW

Person

Somerville, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multispecific molecules and uses thereof
- Patent number 12,134,654
- Issue date Nov 5, 2024
- Marengo Therapeutics, Inc.
- Andreas Loew
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human mesothelin chimeric antigen receptors and uses thereof
- Patent number 11,999,794
- Issue date Jun 4, 2024
- Novartis AG
- Gregory Beatty
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Targeting cytotoxic cells with chimeric receptors for adoptive immu...
- Patent number 11,981,731
- Issue date May 14, 2024
- The Trustees of the University of Pennsylvania
- Gregory Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating solid cancers with bispecific interleukin-anti-T...
- Patent number 11,965,025
- Issue date Apr 23, 2024
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...
- Patent number 11,865,167
- Issue date Jan 9, 2024
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TCR antibody molecules and uses thereof
- Patent number 11,845,797
- Issue date Dec 19, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multispecific antibody molecules comprising lambda and kappa light...
- Patent number 11,673,971
- Issue date Jun 13, 2023
- Marengo Therapeutics, Inc.
- Andreas Loew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using chimeric CD3 receptor proteins
- Patent number 11,667,691
- Issue date Jun 6, 2023
- Novartis AG
- Andreas Loew
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 11,578,130
- Issue date Feb 14, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Sortase synthesized chimeric antigen receptors
- Patent number 11,542,488
- Issue date Jan 3, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multispecific and multifunctional molecules and uses thereof
- Patent number 11,291,721
- Issue date Apr 5, 2022
- Marengo Therapeutics, Inc.
- Andreas Loew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 11,149,076
- Issue date Oct 19, 2021
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Effective targeting of primary human leukemia using anti-CD123 chim...
- Patent number 11,028,177
- Issue date Jun 8, 2021
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using humanized anti-CD19 chimeric antigen rece...
- Patent number 10,927,184
- Issue date Feb 23, 2021
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNA-guided gene editing system and uses thereof
- Patent number 10,738,290
- Issue date Aug 11, 2020
- Novartis AG
- Andreas Loew
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating metabolic disorders with dual function fibrobla...
- Patent number 10,669,323
- Issue date Jun 2, 2020
- Novartis AG
- Brian R. Boettcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human mesothelin chimeric antigen receptors and uses thereof
- Patent number 10,640,569
- Issue date May 5, 2020
- Novartis AG
- Gregory Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeting cytotoxic cells with chimeric receptors for adoptive immu...
- Patent number 10,577,417
- Issue date Mar 3, 2020
- Novartis AG
- Gregory Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cancer with low density lipoprotein-related pro...
- Patent number RE47860
- Issue date Feb 18, 2020
- Novartis AG
- David Jenkins
Information Patent Grant
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...
- Patent number 10,308,717
- Issue date Jun 4, 2019
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Yeast display systems
- Patent number 10,301,616
- Issue date May 28, 2019
- Novartis AG
- Andreas Loew
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 10,287,354
- Issue date May 14, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD20 therapies, CD22 therapies, and combination therapies with a CD...
- Patent number 10,253,086
- Issue date Apr 9, 2019
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Universal fibronectin type III bottom-side binding domain libraries
- Patent number 10,253,313
- Issue date Apr 9, 2019
- Novartis AG
- Andreas Loew
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Treatment of cancer using humanized anti-CD19 chimeric antigen rece...
- Patent number 10,221,245
- Issue date Mar 5, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Yeast display systems
- Patent number 10,041,064
- Issue date Aug 7, 2018
- Novartis AG
- Andreas Loew
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Effective targeting of primary human leukemia using anti-CD123 chim...
- Patent number 9,573,988
- Issue date Feb 21, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMU...
- Publication number 20240317850
- Publication date Sep 26, 2024
- Novartis AG
- Gregory Beatty
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20240301060
- Publication date Sep 12, 2024
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
- Publication number 20240294662
- Publication date Sep 5, 2024
- Novartis AG
- Gregory Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN...
- Publication number 20240238396
- Publication date Jul 18, 2024
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING CHIMERIC CD3 RECEPTOR PROTEINS
- Publication number 20240083968
- Publication date Mar 14, 2024
- Novartis AG
- Andreas Loew
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20240076377
- Publication date Mar 7, 2024
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF
- Publication number 20240002543
- Publication date Jan 4, 2024
- Marengo Therapeutics, Inc.
- Andreas Loew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20230374105
- Publication date Nov 23, 2023
- Novartis AG
- Hans Bitter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230374133
- Publication date Nov 23, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS...
- Publication number 20230357395
- Publication date Nov 9, 2023
- Marengo Therapeutics, Inc.
- Andreas Loew
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY MOLECULES THAT BIND TO NKP30 AND USES THEREOF
- Publication number 20230348593
- Publication date Nov 2, 2023
- Marengo Therapeutics, Inc.
- Andreas Loew
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF DETECTING TRBC1 OR TRBC2
- Publication number 20230333112
- Publication date Oct 19, 2023
- Marengo Therapeutics, Inc.
- Andreas Loew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230272074
- Publication date Aug 31, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODY MOLECULES COMPRISINGLAMBDA AND KAPPA LIGHT C...
- Publication number 20230272119
- Publication date Aug 31, 2023
- Marengo Therapeutics, Inc.
- Andreas Loew
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230227552
- Publication date Jul 20, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED CELL COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20230192848
- Publication date Jun 22, 2023
- Marengo Therapeutics, Inc.
- Andreas Loew
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230174650
- Publication date Jun 8, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230142522
- Publication date May 11, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230127740
- Publication date Apr 27, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIFUNCTIONAL MOLECULES THAT BIND TO CD33 AND USES THEREOF
- Publication number 20230102344
- Publication date Mar 30, 2023
- Marengo Therapeutics, Inc.
- Madan Katragadda
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230048244
- Publication date Feb 16, 2023
- Marengo Therapeutics, Inc.
- Andreas LOEW
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230034161
- Publication date Feb 2, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230031734
- Publication date Feb 2, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
- Publication number 20230025484
- Publication date Jan 26, 2023
- Marengo Therapeutics, Inc.
- Seng-Lai Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230026049
- Publication date Jan 26, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DIMERIZATION SWITCHES AND USES THEREOF
- Publication number 20220378833
- Publication date Dec 1, 2022
- Novartis AG
- Andreas Loew
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF
- Publication number 20220288200
- Publication date Sep 15, 2022
- Marengo Therapeutics, Inc.
- Andreas LOEW
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CSF1R/CCR2 MULTISPECIFIC ANTIBODIES
- Publication number 20220242957
- Publication date Aug 4, 2022
- Marengo Therapeutics, Inc.
- Andreas LOEW
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...
- Publication number 20220195010
- Publication date Jun 23, 2022
- Novartis AG
- Hans Bitter
- C07 - ORGANIC CHEMISTRY

Andreas LOEW

Person

Patents Grantslast 30 patents

Multispecific molecules and uses thereof

Human mesothelin chimeric antigen receptors and uses thereof

Targeting cytotoxic cells with chimeric receptors for adoptive immu...

Method of treating solid cancers with bispecific interleukin-anti-T...

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...

Anti-TCR antibody molecules and uses thereof

Multispecific antibody molecules comprising lambda and kappa light...

Treatment of cancer using chimeric CD3 receptor proteins

Treatment of cancer using a CD123 chimeric antigen receptor

Regulatable chimeric antigen receptor

Sortase synthesized chimeric antigen receptors

Multispecific and multifunctional molecules and uses thereof

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Effective targeting of primary human leukemia using anti-CD123 chim...

Treatment of cancer using humanized anti-CD19 chimeric antigen rece...

RNA-guided gene editing system and uses thereof

Treatment of cancer using a CD123 chimeric antigen receptor

Methods of treating metabolic disorders with dual function fibrobla...

Human mesothelin chimeric antigen receptors and uses thereof

Targeting cytotoxic cells with chimeric receptors for adoptive immu...

Methods of treating cancer with low density lipoprotein-related pro...

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...

Yeast display systems

Regulatable chimeric antigen receptor

CD20 therapies, CD22 therapies, and combination therapies with a CD...

Universal fibronectin type III bottom-side binding domain libraries

Treatment of cancer using humanized anti-CD19 chimeric antigen rece...

Yeast display systems

Treatment of cancer using a CD123 chimeric antigen receptor

Effective targeting of primary human leukemia using anti-CD123 chim...

Patents Applicationslast 30 patents

TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMU...

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN...

TREATMENT OF CANCER USING CHIMERIC CD3 RECEPTOR PROTEINS

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS...

ANTIBODY MOLECULES THAT BIND TO NKP30 AND USES THEREOF

METHODS OF DETECTING TRBC1 OR TRBC2

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

MULTISPECIFIC ANTIBODY MOLECULES COMPRISINGLAMBDA AND KAPPA LIGHT C...

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

ENGINEERED CELL COMPOSITIONS AND METHODS OF USE THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

MULTIFUNCTIONAL MOLECULES THAT BIND TO CD33 AND USES THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

DIMERIZATION SWITCHES AND USES THEREOF

MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF

CSF1R/CCR2 MULTISPECIFIC ANTIBODIES

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD...